Amarin adds another supplier for Vascepa

Amarin Corp. plc said Tuesday that it has added another supplier for the active ingredient in its heart medication Vascepa.

Amarin, with research headquarters in Groton, said a consortium of companies led by Canada-based Slanmhor Pharmaceuticals Inc. will be its fourth supplier of highly purified omega-3 fish oil.

Amarin's stock price immediately tanked 10 percent on the news, as investors expecting to hear encouraging words about the company's application to have Vascepa declared a new chemical entity were disappointed, according to investment website.

"Today's announcement simply wasn't enough to get investors' minds off that pesky NCE status," the website said.


Loading comments...
Hide Comments